Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

11.8%

2 terminated/withdrawn out of 17 trials

Success Rate

88.2%

+1.7% vs industry average

Late-Stage Pipeline

82%

14 trials in Phase 3/4

Results Transparency

67%

10 of 15 completed trials have results

Key Signals

10 with results

Enrollment Performance

Analytics

Phase 4
13(76.5%)
N/A
3(17.6%)
Phase 3
1(5.9%)
17Total
Phase 4(13)
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT04124510Phase 3Terminated

Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy

Role: lead

NCT03768466Phase 4Completed

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

Role: lead

NCT02660229Phase 4Completed

An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.

Role: lead

NCT02491970Phase 4Terminated

Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol

Role: lead

NCT02660541Not ApplicableCompleted

Burn Wound Management of Betafoam® and Allevyn® Ag

Role: lead

NCT01313780Phase 4Completed

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

Role: lead

NCT02732886Not ApplicableCompleted

Betafoam Diabetes Mellitus Foot Study

Role: lead

NCT02543034Not ApplicableCompleted

Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site

Role: lead

NCT01811186Phase 4Completed

An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)

Role: lead

NCT01675531Phase 4Completed

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Role: lead

NCT01961271Phase 4Completed

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Role: collaborator

NCT01719757Phase 4Completed

PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain

Role: lead

NCT02072200Phase 4Completed

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

Role: lead

NCT01983111Phase 4Completed

Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)

Role: lead

NCT01811238Phase 4Completed

An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

Role: lead

NCT01818700Phase 4Completed

An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders

Role: lead

NCT01019265Phase 4Completed

A Study Comparing Norspan Patch and Oral Tramadol

Role: lead

All 17 trials loaded